Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Ruth's Hospitality Q1 Earnings Beat Estimates

Ruth's Hospitality Group Inc (NASDAQ:RUTH) reported first-quarter FY22 sales growth of 44.5% year-on-year, to $126.13 million, beating the consensus of $118.02 million. Comparable Restaurant Sales jumped 41.5% versus last year and 8.1% versus 2019. Restaurant sales amounted to $118.7 million, and Franchise income was $4.7 million. Food and beverage costs, as a percentage…

Benzinga

Earnings Outlook For FibroGen

FibroGen (NASDAQ:FGEN) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that FibroGen will report an earnings per share (EPS) of $-0.83.

Benzinga

Berkeley Lights's Earnings Outlook

Berkeley Lights (NASDAQ:BLI) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Berkeley Lights will report an earnings per share (EPS) of $-0.31.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Aterian's Earnings Outlook

Aterian (NASDAQ:ATER) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Aterian will report an earnings per share (EPS) of $-0.25.

Benzinga

Apple Whale Trades For May 06

Someone with a lot of money to spend has taken a bearish stance on Apple (NASDAQ:AAPL). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

7 Analysts Have This to Say About Ansys

Analysts have provided the following ratings for Ansys (NASDAQ:ANSS) within the last quarter:

Benzinga

A Preview Of Aziyo Biologics's Earnings

Aziyo Biologics (NASDAQ:AZYO) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Aziyo Biologics will report an earnings per share (EPS) of $-0.62.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Infrastructure and Energy's Earnings Outlook

Infrastructure and Energy (NASDAQ:IEA) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Infrastructure and Energy will report an earnings per share (EPS) of $-0.12.

Benzinga

This Is What Whales Are Betting On Roku

Someone with a lot of money to spend has taken a bearish stance on Roku (NASDAQ:ROKU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Chinese Analyst Who Projected Bearish Reports On Alibaba And Other Chinese Stocks Returns To Twitter

The former China strategist at Bocom International Holdings was active again on Twitter, Inc (NYSE:TWTR) with a forecast on the Nasdaq index, just days after he exited the state-owned brokerage following a ban by Chinese social media, Bloomberg reports. Hong Hao posted a chart on Twitter that compared the Nasdaq's bubble in 2000 to its…

Benzinga

Expert Ratings for ProQR Therapeutics

Within the last quarter, ProQR Therapeutics (NASDAQ:PRQR) has observed the following analyst ratings:

Benzinga

Earnings Preview: FedNat Holding

FedNat Holding (NASDAQ:FNHC) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that FedNat Holding will report an earnings per share (EPS) of $-1.35.

Benzinga

This Is What Whales Are Betting On NVIDIA

A whale with a lot of money to spend has taken a noticeably bearish stance on NVIDIA. Looking at options history for NVIDIA (NASDAQ:NVDA) we detected 10 strange trades.

Benzinga

Arcturus Therapeutics's Earnings Outlook

Arcturus Therapeutics (NASDAQ:ARCT) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Arcturus Therapeutics will report an earnings per share (EPS) of $-1.44.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Expert Ratings for CryoPort

Over the past 3 months, 5 analysts have published their opinion on CryoPort (NASDAQ:CYRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Preview: i3 Verticals's Earnings

i3 Verticals (NASDAQ:IIIV) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that i3 Verticals will report an earnings per share (EPS) of $0.35.

Benzinga

Earnings Preview For GTY Technology Holdings

GTY Technology Holdings (NASDAQ:GTYH) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that GTY Technology Holdings will report an earnings per share (EPS) of $-0.12.

Benzinga

How Is The Market Feeling About T-Mobile US?

T-Mobile US's (NASDAQ:TMUS) short percent of float has risen 19.12% since its last report. The company recently reported that it has 17.76 million shares sold short, which is 2.99% of all regular shares that are available for trading.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99.

Benzinga

Where BridgeBio Pharma Stands With Analysts

BridgeBio Pharma (NASDAQ:BBIO) has observed the following analyst ratings within the last quarter:

Benzinga

Allegiance Bancshares's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Allegiance Bancshares (NASDAQ:ABTX) posted Q1 earnings of $18.66 million, an increase from Q4 of 13.46%. Sales dropped to $59.19 million, a 2.26% decrease between quarters.

Benzinga

Syneos Health's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) posted Q1 earnings of $46.18 million, an increase from Q4 of 39.21%. Sales dropped to $1.34 billion, a 2.69% decrease between quarters.

Benzinga

Charter Communications Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, Charter Communications (NASDAQ:CHTR) posted Q1 earnings of $1.39 billion, an increase from Q4 of 24.26%. Sales dropped to $13.20 billion, a 0.09% decrease between quarters.

Benzinga

Looking Into Newell Brands's Return On Invested Capital

Pulled from Benzinga Pro data, Newell Brands (NASDAQ:NWL) posted Q1 earnings of $234.00 million, an increase from Q4 of 143.75%. Sales dropped to $2.39 billion, a 14.87% decrease between quarters.

Benzinga

NorthWestern's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, NorthWestern (NASDAQ:NWE) earned $59.11 million, a 15.14% increase from the preceding quarter. NorthWestern also posted a total of $394.50 million in sales, a 13.58% increase since Q4.

1 … 553 554 555 556

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.